Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 26, 2017

Primary Completion Date

March 30, 2018

Study Completion Date

March 30, 2018

Conditions

Peanut Allergy

Interventions

DRUG

Etokimab

Humanized monoclonal antibody, administered by intravenous infusion

DRUG

Placebo

Administered by intravenous infusion

Trial Locations (2)

Stanford Univ. Medical Center, Palo Alto

Asthma, Inc Clinical Research Center, Seattle